Browse the complete record of transactions filed by Boulding Mark Elliott, Vice-Président Exécutif et Directeur Juridique. Director active across 1 companies, notably PTC Therapeutics, INC.. In total, 12 disclosures have been logged. Total volume traded: €116k. The latest transaction was filed on 13 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Mark Elliott Boulding serves as Executive Vice President and Chief Legal Officer at PTC THERAPEUTICS, INC. He oversees the company's legal affairs, ensuring compliance with regulations and protecting PTC's interests. With expertise in business law and risk management, he plays a key role in the legal and business strategy of the company. His experience enables him to effectively navigate the complex legal challenges that PTC may face.